Michael S. Brown - 09 Aug 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Michael S. Brown
Issuer symbol
REGN
Transactions as of
09 Aug 2021
Net transactions value
-$1,033,085
Form type
4
Filing time
10 Aug 2021, 17:00:54 UTC
Previous filing
28 Jun 2021
Next filing
15 Sep 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $1,033,085 -1,687 -18% $612.38 7,662 09 Aug 2021 by Trust
holding REGN Common Stock 891 09 Aug 2021 Direct
holding REGN Common Stock 5,000 09 Aug 2021 by SLAT F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.